Table 1 Baseline Characteristics Post PSWM
DP-DES (700 pt.) | BP-DES (700 pt.) | P | |
|---|---|---|---|
Age (mean ± SD) | 70.7 ± 9 | 70.7 ± 10 | 0.97 |
Female (%) | 20.5 | 23.1 | 0.24 |
Hypertension (%) | 77.1 | 73.8 | 0.17 |
Hyperlipidemia (%) | 62 | 63.8 | 0.5 |
Diabete mellitus non ID (%) | 26.2 | 27.8 | 0.5 |
Diabete mellitus ID (%) | 6.4 | 9.5 | 0.09 |
Previous smoker (%) | 31.8 | 30.3 | 0.5 |
Renal Disease (gfr < 60 ml/min/m2) (%) | 19.7 | 19.9 | 0.71 |
Previous PCI (%) | 32 | 33.6 | 0.57 |
Previous CABG (%) | 4.9 | 4.4 | 0.7 |
Previous MI (%) | 31.8 | 36 | 0.1 |
ASA + Clopidogrel (%) | 64.3 | 66.4 | 0.25 |
ASA + Ticagrelor (%) | 24.2 | 23.8 | 0.22 |
ASA + Prasugrel (%) | 7.6 | 8.0 | 0.11 |
Length of DAPT (months) | 11.3 | 11.7 | 0.34 |
Indication for PCI: (%) | 0.1 | ||
- STEMI | 19 | 18.1 | |
- NSTEMI | 25.4 | 27.8 | |
- UA | 18.2 | 14.7 | |
- Stable angina | 14.9 | 21.6 | |
- Planned angiographic follow up | 7.1 | 4.9 |